SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Changes

25 Sep 2025 07:00

RNS Number : 6929A
Porvair PLC
25 September 2025
 

 

For immediate release 25 September 2025

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Board Changes

Lisa Anson

Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025.

Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI).

Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland.

On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair.

Porvair confirms that there are no further matters in relation to Lisa Anson's appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.

Sally Martin

Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025.

Sheena Mackay

Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

Andrew Douglass, Group Company Secretary

 

Burson Buchanan

+44 (0)207 466 5000

Charles Ryland / Stephanie Whitmore

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEZLFLEKLZBBF
Date   Source Headline
26th Jun 20137:00 amRNSDirectors' Shareholdings and Issue of Equity
24th Jun 20136:17 pmRNSHolding(s) in Company
24th Jun 20137:00 amRNSInterim Results
21st Jun 20139:02 amRNSBlocklisting application
5th Jun 20137:00 amRNSAcquisition and Trading Update
31st May 201312:01 pmRNSTotal Voting Rights
16th Apr 20134:02 pmRNSDirectors' Shareholdings and Issue of Equity
16th Apr 20132:39 pmRNSAGM resolutions and notice of filings
16th Apr 20137:00 amRNSAGM Statement, IMS and Contract extension
28th Feb 201310:00 amRNSTotal Voting Rights
13th Feb 20137:00 amRNSContract Win
5th Feb 20136:16 pmRNSHolding(s) in Company
5th Feb 20134:40 pmRNSHolding(s) in Company
28th Jan 201312:28 pmRNSBlocklisting Application
28th Jan 20137:00 amRNSResults for the year ended 30 November 2012
11th Jan 20137:00 amRNSContract Win
30th Nov 20128:48 amRNSHolding(s) in Company
29th Nov 201211:32 amRNSHolding(s) in Company
29th Nov 201210:29 amRNSDirector/PDMR Shareholding
28th Nov 20127:00 amRNSPre-close trading update
28th Sep 201212:34 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSInterim Management Statement
2nd Aug 20127:00 amRNSDirectorate Change
12th Jul 20129:38 amRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSInterim Results
24th May 20127:00 amRNSTrading Update
19th Apr 20127:00 amRNSDirector/PDMR Shareholding
18th Apr 20127:00 amRNSAcquisition of Pulse Instrumentation
11th Apr 20123:57 pmRNSResult of AGM
11th Apr 20127:00 amRNSAGM Statement and IMS
7th Mar 20129:21 amRNSPosting of Annual Report and Accounts
5th Mar 20127:00 amRNSAcquisition
2nd Mar 201211:54 amRNSTotal Voting Rights
31st Jan 20127:00 amRNSPreliminary Results
30th Dec 20117:00 amRNSTotal Voting Rights
8th Dec 20119:21 amRNSHolding(s) in Company
6th Dec 20117:00 amRNSPre-close trading update and acquisition
30th Nov 20117:00 amRNSTotal Voting Rights
23rd Nov 20117:00 amRNSContract win
7th Nov 20114:44 pmRNSAnnual Information Update
4th Nov 20112:57 pmRNSTotal Voting Rights
26th Oct 20118:20 amRNSHolding(s) in Company
6th Oct 20117:00 amRNSChange in Director's details
5th Oct 20112:30 pmRNSNotification of Major Interest in Shares
5th Oct 20112:24 pmRNSNotification of Major Interest in Shares
4th Oct 20117:00 amRNSIssue of equity and Directors' shareholdings
21st Sep 20117:00 amRNSDirectors' Dealing
20th Sep 20117:00 amRNSInterim Management Statement
31st Aug 20116:07 pmRNSHolding(s) in Company
31st Aug 20116:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.